surmount-osa trial tirzepatide results VisualAbstract: Improved Outcomes in Patients with Obstructive Sleep Apnea and Obesity Terzapatid in Managing OSA

Interestingly, when comparing the nocturnal plasma levels between individuals with schizophrenia and MDD, it was found that the levels in MDD are lower than those seen in schizophrenia 130

Time dependence refers to the pattern of side effects being most prominent during treatment initiation and dose increases, then declining as the body adapts

Among the possible mechanisms underlying DDIs, those related to delayed gastric emptying have been most extensively studied

@SArunogiri @MonashUni The Conversation Australia + New Zealand (@ConversationEDU) March 5, 2026 Another major study added more evidence by examining substance use outcomes